Addendum dated March 30, 2010 to License Agreement dated December 21, 2006



 Exhibit 10.1 

Addendum to License Agreement dated 21st of December 2006 

between Adept Technology and Fundacion Fatronik. 
  

	I.	License Fees 

 The
license agreement from December 2006 agreement specifies license fees according to the following schedule starting July 1, 2007 for robots sold into regions that are covered by exclusivity: 

 

					
	 Year 1:
	  	  800 US$	  	(Adept Fiscal Year 2008)
	 Year 2:
	  	  800 US$	  	(Adept Fiscal Year 2009)
	 Year 3:
	  	1600 US$	  	(Adept Fiscal Year 2010)
	 Year 4:
	  	1400 US$	  	(Adept Fiscal Year 2011)
	 Year 5:
	  	1200 US$	  	(Adept Fiscal Year 2012)
	 Year 6:
	  	1000 US$	  	(Adept Fiscal Year 2013)
	 Year 7:
	  	  800 US$	  	(Adept Fiscal Year 2014)
	 Year 8:
	  	  600 US$	  	(Adept Fiscal Year 2015)
	
	Starting with Year 3 (July 1st, 2009) the license fees have changed as follows:
			
	 Year 1:
	  	800 US$	  	(Adept Fiscal Year 2008)
	 Year 2:
	  	800 US$	  	(Adept Fiscal Year 2009)
	 Year 3:
	  	1200 US$	  	(Adept Fiscal Year 2010)
	 Year 4:
	  	1300 US$	  	(Adept Fiscal Year 2011)
	 Year 5:
	  	1400 US$	  	(Adept Fiscal Year 2012)
	 Year 6:
	  	1200 US$	  	(Adept Fiscal Year 2013)
	 Year 7:
	  	1000 US$	  	(Adept Fiscal Year 2014)
	 Year 8:
	  	800 US$	  	(Adept Fiscal Year 2015)

  

	II.	Exclusivity and Minimum Unit Volume 


Licensee gives up exclusivity in Russia. Therefore the minimum unit volume to keep exclusivity changes from [ ********** ] CONFIDENTIAL
TREATMENT REQUESTED units per year. Starting with year 3, the yearly minimum unit volume is a worldwide number and is independent on geographies. 

Licensor agrees to keep patent(s) alive in Russia until year [ ********** ] CONFIDENTIAL TREATMENT REQUESTED. 

 
 [ ********** ] CONFIDENTIAL INFORMATION MARKED BY BRACKETS HAS BEEN OMITTED
AND AN UNREDACTED VERSION FILED SEPARATELY WITH THE SEC PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED 








	III.	Forecast 

 Licensee
forecasts the following unit volumes for the respective periods: 
 Year 3: [ ********** ] CONFIDENTIAL TREATMENT
REQUESTED 
 1st Half:   [ ********** ] CONFIDENTIAL TREATMENT REQUESTED 

2nd Half : [ ********** ] CONFIDENTIAL TREATMENT REQUESTED 

Year 4: [ ********** ] CONFIDENTIAL TREATMENT REQUESTED 

1st Half:   [ ********** ] CONFIDENTIAL TREATMENT REQUESTED 

2nd Half : [ ********** ] CONFIDENTIAL TREATMENT REQUESTED 

Year 5: [ ********** ] CONFIDENTIAL TREATMENT REQUESTED 

1st Half:   [ ********** ] CONFIDENTIAL TREATMENT REQUESTED 

2nd Half   [ ********** ] CONFIDENTIAL TREATMENT REQUESTED 

Broken down into Calendar years the forecast is as follows: 

CY 2010: [ ********** ] CONFIDENTIAL TREATMENT REQUESTED 

CY 2011: [ ********** ] CONFIDENTIAL TREATMENT REQUESTED 

 

	IV.	License Fee Calculation 


Licensor has the option to ‘borrow’ unit volume from a future period for license fee calculation should the cumulated license
fee for a given calendar year be below 200,000 Euro. The goal is to generate a minimum license fee for a particular year. Should Licensor choose to use this option, that total license fee amount for the particular calendar year may not exceed
205,000 Euro Unit volumes borrowed from the future period need to be reconciled during the next period in order to accurately reflect real unit sales for the next period. 

 

					
	ADEPT TECHNOLOGY, INC.	  		  	Fundacion Fatronik
			
	By                             
                                         
                                	  		  	By                             
                                         
                        
			
	(Print)                            
                                         
                          	  		  	(Print)                            
                                         
                   
			
	Title                             
                                         
                            	  		  	Title                            
                                         
                      
			
	Date                             
                                         
                            	  		  	Date                            
                                         
                      

  

[ ********** ] CONFIDENTIAL INFORMATION MARKED BY BRACKETS HAS BEEN OMITTED AND AN UNREDACTED VERSION FILED SEPARATELY WITH THE SEC PURSUANT TO RULE 24B-2
OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED